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Abstract
A novel peptide–lipid sensitive to enzyme cleavage was designed to generate liposomes that could be triggered to fuse
 .by enzymatic activation. Covalent linkage of dioleoyl phosphatidylethanolamine DOPE to an elastase substrate, N-acetyl-
 .ala–ala-, resulted in a cleavable peptide–lipid N-Ac-AA-DOPE with no intrinsic fusogenic activity. Cleavage of
N-Ac-AA-DOPE and concomitant conversion to the fusogenic lipid DOPE could be detected after treatment with human
leukocyte elastase or proteinase K, two proteases with similar substrate specificities. A strategy to utilize this cleavage to
trigger fusogenicity was tested by modeling the fusion of liposomes containing the expected product of complete cleavage.
Based on these results liposomes were designed to contain N-Ac-AA-DOPE, DOTAP, and PE in the ratio of 15r15r70.
These liposomes exhibited lipid mixing with acceptor liposomes after elastase or proteinase K protease treatment.
 .Activation of fusion, as monitored by a lipid mixing assay, appeared to be dependent on protease activity, as 1 heat
 .inactivated enzyme did not activate liposomal fusion, and 2 the time and concentration dependence of proteinase K
mediated cleavage of N-Ac-AA-DOPE correlated with membrane mixing. Liposomes could also be formulated that
exhibited lipid mixing and transfer of aqueous fluorescent probe with erythrocyte ghosts. These observations demonstrate
fusogenic lipids conjugated to enzyme substrates serve as triggerable fusion systems that may be useful for gene and drug
delivery. q 1998 Elsevier Science B.V. All rights reserved.
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Abbreviations: DOPE 1,2-Dioleoyl-sn-glycero-3-phos-
. phatidylethanolamine ; N-Ac-AA-DOPE N-acetyl alanine ala-
.nine 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine ; PS
 .  phosphatidylserine ; N-NBD-PS N- 7-nitrobenz-2-oxa-1,3-di-
. . azol-4-yl PS ; N-Rho-PE N-lissamine rhodamine B sulfo-
. .  .nyl PE ; DOTAP dioleoyl trimethylammonium propane ; LUV
 .  .large unilamellar vesicle ; SUV small unilamellar vesicle ;
 .  wC12E8 octaethylene glycol monododecyl ether ; TES N-tris hy-
x . droxymethyl methyl-2-aminoethanesulfonic acid ; EDTA ethyl-
.  . enediamine tetraacetic acid ; H inverted hexagonal ; RET res-II
.  .onance energy transfer ; RFU relative fluorescence units
) Corresponding author.
1. Introduction
Specific delivery of encapsulated drugs or genes to
cells by liposomes is dependent upon fusion between
liposomal and cell membranes. Promotion of liposo-
mal fusion is achieved by inclusion of lipids capable
 .of undergoing the lamellar L to inverted hexago-a
 .nal H phase transition, which is associated withII
w xenhanced fusogenicity 1,2 . Unfortunately, lipo-
somes containing these lipids exhibit unregulated fu-
sion. In the context of in vivo delivery, it is desirable
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to formulate liposomes that are not fusogenic until
activated by a specific trigger. In this way the lipo-
somes and their contents retain stability and reduce
non-specific fusion until present at the site of in-
tended intervention. Liposomes have been previously
developed that rely upon a variety of triggers to
activate their fusogenic or membrane destabilization
potential. These triggering signals include pH sensi-
w x w xtive lipids 3–7 , photoactivation 7,8 , phospholipase
w x w xC activity 9,10 , chemical cleavage 11 , and trypsin
w xmediated cleavage 12 .
Another approach to creating a triggerable fuso-
genic liposome is to rely upon a physiologically
relevant signal that is associated with a pathological
state. Specifically, the modification of DOPE by
covalent conjugation of the headgroup to an enzyme
substrate may mask its fusogenic potential until
cleaved by the specific enzyme. DOPE is of interest
because its tendency to form non-bilayer structures is
w xassociated with its ability to promote fusion 1 . Pure
DOPE does not form stable membrane bilayers at
physiological pH, instead organizing into H struc-II
w xtures 13 . However, certain modifications of the PE
headgroup generate phospholipids that are capable of
forming stable lamellar membranes. For example,
w xboth mono-methylated PE 14,15 and negatively
 .charged phosphatidylserine PS can be formulated
into stable liposomes. This indicates the addition of a
bulkier headgroup andror charged group to PE in-
hibits the non-bilayer forming aspect of this phospho-
lipid. Therefore, addition of an enzyme susceptible
peptide to the headgroup of DOPE, resulting in in-
creased headgroup size and conversion to a nega-
tively charged lipid, may create a novel phospholipid
capable of forming stable liposomal membranes.
Possible candidates for an enzyme substrate to
attach to DOPE are numerous. Elastase, an enzyme
released from the azurophil granules of activated
neutrophils, is of particular interest because of its
ubiquitous involvement in inflammatory and tumori-
genic conditions. In addition, the ability of elastase to
w xrecognize a simple peptide sequence 16 simplifies
the coupling of the substrate to DOPE, as well as
potentially limiting the immunogenicity of the pep-
tide–lipid.
In this report we describe the conjugation of the
N-Ac-ala–ala peptide to the headgroup of DOPE,
 .generating a peptide–lipid N-Ac-AA-DOPE that
acts as the triggering component in a fusogenic lipo-
some. Cleavage of N-Ac-AA-DOPE is in fact associ-
ated with activation of liposomal fusion. The design
of such a liposome has immediate implications for
delivery to inflammatory sites, as well as providing a
rationale for expanding the repertoire of peptide–
lipids for potential delivery to other pathological sites
involving elevated enzyme concentrations.
2. Materials and methods
2.1. Reagents
Human leukocyte elastase was purchased from
 .Calbiochem San Diego, CA . Phenylmethylsulfonyl
 .  .fluoride PMSF , and trifluoroacetic acid TFA were
 .purchased from Sigma Chemical St. Louis, MO .
Proteinase K was purchased from Sigma and
 .Boehringer Mannheim Indianapolis, IN . Lipids were
 .purchased from Avanti Polar Lipids Alabaster, AL
and were of 99% or greater purity. TX-red dextrans
 .were from Molecular Probes Eugene, OR . Trieth-
 .ylamine Et N was obtained from Fluka Chemical3
 .  .Ronkonkoma, NY . Dry tetrahydrofuran THF ,
 .Celite and 1,3-Dicyclohexylcarbodiimide DCC were
 .from Aldrich Chemicals Milwaukee, WI . Ac-ala–
ala-OH used for covalent linkage with DOPE was
 .from Bachem Bioscience King of Prussia, PA .
Packed red blood cells were purchased from Analyti-
 .cal Biological Systems Wilmington, DE . Hexane
and isopropanol were obtained from Burdick and
 .Jackson Muskegon, MI . Unless otherwise specified,
buffer used was 10 mM TES, 154 mM NaCl, 0.1 mM
EDTA, pH 7.4. All experiments conducted with hu-
man leukocyte elastase were performed using the
same buffer adjusted to pH 8.8.
2.2. Synthesis and characterization of N-acetyl ala-
nine alanine 1,2-Dioleoyl-sn-glycero-3-phosphatidyl-
( )ethanolamine N-Ac-AA-DOPE
 .N-Acetyl AA-OH 25 mg, 0.12 mmol , dissolved
in 5 ml of dry THF, was stirred for 24 h at room
 .temperature with DCC 25 mg, 0.12 mmol , DOPE
 . 50 mg, 0.06 mmol and excess of Et N 100 ml, 0.73
.mmol . The white precipitate of dicyclohexyl urea
was filtered through a Celite bed and the filtrate was
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concentrated. The product was purified by prepara-
 .tive TLC using CHCl :MeOH:H O 60:15:2 to yield3 2
23 mg as a white flaky powder. The product was
1 characterized by TLC and H NMR 300 MHz,
.CDCl . Purity was 90% or greater. The resulting3
 .peptide–lipid N-Ac-AA-DOPE resolved as a single
 .spot by TLC Fig. 2 and generated a single peak by
 .reverse-phase HPLC unpublished data . A predomi-
nant single peak was also observed by 31P-NMR
analysis, although this technique detected a small
 .amount -10% of an apparent impurity that was
 .present in all batches unpublished data .
2.3. Liposome preparation
 .Large unilamellar vesicles LUVs were prepared
by aliquoting desired amounts of lipid into 16=100
mm pyrex tubes from chloroform stocks and drying
under a nitrogen stream. After exposure to high
vacuum 4 h overnight, the lipid film was hydrated in
TESrNaClrEDTA buffer. After vortexing, samples
were freeze–thawed 8= and extruded under pressure
 .10= Lipex, Vancouver, BC, Canada through 0.1
mm polycarbonate filters Nucleopore, Pleasanton,
.CA . Liposomes were stored at 48C until used. Dex-
tran loaded liposomes were prepared by hydrating the
lipid film in the presence of buffer containing 10 kDa
 .TX-red dextran 50 mgrml . Liposomes were then
prepared as described above. Small unilamellar vesi-
 .cles SUVs were prepared by drying lipid in the
same manner as described above but preparations
were water bath sonicated after vortexing for )10
min at room temperature. Lipid concentration was
w xmonitored by phosphate assay 17 . The size of lipo-
somes was verified by quasi-elastic light scattering
using a Nicomp Submicron Particle Sizer Particle
.Sizing Systems, Santa Barbara, CA . LUVs and SUVs
were 70–80 nm and 35–45 nm in diameter, respec-
tively.
2.4. RBC ghost preparation
w xGhosts were prepared as described previously 18 .
Briefly, washed RBC were hypotonically lysed at 48C
by addition of 10 mM Tris, 2 mM MgCl , 0.1 mM2
EGTA, 0.1% BSA, pH 7.4. After 2 min, isotonicity
was restored by addition of 1.22 M NaCl, 30 mM
KCl, 0.15 M Na HPO , 50 mM KH PO , 1 mM2 4 2 4
MgCl , pH 7.4. Cells were incubated at 378C for 402
min, then washed 3= with the appropriate buffer for
the planned experiments.
2.5. Detection of N-Ac-AA-DOPE clea˝age
2.5.1. TLC detection of N-Ac-AA-DOPE clea˝age
About 100–200 nmol of N-Ac-AA-DOPE SUVs
were incubated with 1 mg enzyme in 0.1 ml overnight
at 378C. Lipid was extracted by organic phase separa-
w xtion 19 twice. Collected lipid was dried under N2
stream and exposed to vacuum for 4 h overnight.
Samples were resuspended in chloroform and spotted
onto TLC plates. TLC was run using
 .chloroformrmethanolrwater 65:25:4 , air dried,
sprayed with molybdenate blue, and charred on a hot
plate.
2.5.2. HPLC detection of N-Ac-AA-DOPE clea˝age
Liposomes composed of DOTAPrN-Ac-AA-
 .DOPE 1:1 or DOTAPrN-Ac-AA-DOPErPE
 .15r15r70 mol% were incubated with enzyme un-
der given conditions. Lipid was extracted by the
w xBligh Dyer procedure 19 twice. Collected lipid was
dried under N stream and exposed to vacuum for 4 h2
overnight. Samples were resuspended in 100% ethanol
and injected in 30 ml aliquots into Spherisorb silica
columns 150=4.6 mm, 0.3 mm, Keystone Scien-
.tific . HPLC was performed using a hexane:isopro-
panol:water:TFA mobile phase. Hexane and TFA
were held constant at 37% and 0.2%, respectively.
The N-Ac-AA-DOPE peak was detected using a
gradient of 59–55% isopropanol:4–8% water. Flow
rate was 1.5 mlrmin, column temperature was set at
458C, and peaks were detected by a UV detector set
at 205 nm. Lipid peaks were quantitated in compari-
son to standard curves generated by injecting 5–200
nmol of DOTAP or N-Ac-AA-DOPE and monitoring
205 nm signal. Percent cleavage was calculated by
normalizing peaks to DOTAP which is not cleaved
.by enzyme treatment, unpublished observation , then
determining the decrease in N-Ac-AA-DOPE peak
size relative to starting amounts.
2.5.3. 31P-NMR analysis
N-Ac-AA-DOPE LUVs were prepared and treated
with or without proteinase K 1.5 mg proteinr100
.nmol lipid overnight at 378C. Samples were mixed
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with buffer 10% deoxycholate, 100 mM EDTA, 20
. mM Hepes and deuterium oxide Cambridge Isotope
.  .Laboratories, Woburn, MA 1:4:2 and transferred to
5 mm NMR tubes. Samples were monitored at room
temperature in a Bruker AC300 spectrometer operat-
ing at 121.5 MHz, with 110 ms 908 radio frequency
pulse for proton decoupling and set to 2 s interpulse
delay to avoid signal saturation. Sweep width was set
at 50 kHz. A 1 Hz line broadening was applied to all
spectra.
2.6. Lipid mixing assay
Lipid mixing was monitored by the N-NBD-
PErN-Rho-PE resonance energy transfer assay, as
w xdescribed 20 . Liposomes were prepared with 1 mol%
N-NBD-PE and 1 mol% N-Rho-PE, which results in
quenching of the N-NBD-PE fluorescence signal.
Membrane fusion results in probe diffusion and relief
from self-quenching, which is monitored as an in-
crease in N-NBD-PE fluorescence. Liposome–lipo-
some lipid mixing was initiated by addition of 10
nmol of fluorescently labeled liposomes to 90 nmol
unlabeled liposomes in microcentrifuge tubes con-
taining 1 ml of TESrNaClrEDTA buffer with 1.5
mM Caqqr1.5 mM Mgqq. For fusion with cells
1=108 RBC ghosts were substituted for unlabeled
liposomes. All samples were shaken in an Eppendorf
Thermomixer Brinkmann Instruments, Westbury,
.NY , 700 rpmrmin, during the 378C incubation for
30 min. N-NBD-PE fluorescence was monitored in a
T-format PTI Alphascan spectrafluorometer Prince-
.ton, NJ with a xenon short arc lamp using 450 nm
excitationr530 nm emission wavelengths and 5 nm
slitwidths. Band pass of 450 nm and 500 nm cutoff
filters were utilized for excitation and emission light
paths, respectively, to reduce stray light. Maximal
fluorescence dequenching was determined by addi-
tion of 0.1% C12E8 detergent.
2.7. Protease acti˝ation of fusion
Liposomes were incubated with protease at a 1 mg
proteaser100 nmol lipidr0.1 ml buffer ratio, unless
otherwise stated. This concentration of proteinase K
was found to have comparable activity, within an
order of magnitude, with that of elastase in rheuma-
ww x xtoid arthritis synovial fluid 21 ; unpublished data .
Mixtures were incubated at 378C in microcentrifuge
tubes with constant shaking in an Eppendorf Ther-
momixer, 700 rpmrmin. Treated liposomes were then
assayed for N-Ac-AA-DOPE cleavage by HPLC, as
described above. For fusion experiments liposomes
containing fluorescent membrane probes were treated
with protease and then the concentrations of lipo-
somes were determined by monitoring direct N-Rho-
 .PE fluorescence 550exr590em and comparing with
a known amount of stock liposomes. Aliquots of
these fluorescently labeled protease treated liposomes
were incubated with unlabeled target liposomes or
cells and lipid mixing was determined as described
above.
2.8. Fluorescence microscopy of dextran deli˝ery
from liposomes to RBC ghosts
 .DOTAPrN-Ac-AA-DOPErPE 20r10r70 mol%
liposomes loaded with 10 kDa TX-red dextran were
incubated overnight at 378C with proteinase K. Some
10 nmol aliquots were incubated with 1=108 RBC
ghosts in 1 ml buffer for 30 min at 378C. Cells were
washed with buffer 3= to remove unbound lipo-
somes. The cell pellet was resuspended in 0.1 ml
buffer and observed under an Olympus BH-2 fluores-
 .cence microscope Olympus, Lake Success, NY us-
 .ing an apochromat 40= oil N.A. 1.00 objective.
TX-red fluorescence was excited by a xenon lamp
transmitted through a green excitation cube 580 nm
.dichroic mirror, 545 nm excitation filter . Non-fluo-
rescent images were observed with transmitted light
Nomarski differential interference contrast mi-
croscopy.
3. Results
3.1. N-Ac-AA-DOPE clea˝age by elastase
We postulated that covalent conjugation of an
enzyme substrate to the headgroup of DOPE would
create a novel peptide–lipid with limited fusogenicity
that could be reactivated to fuse upon removal of the
 .substrate by enzymatic cleavage Fig. 1 . The elastase
substrate, N-Ac-ala–ala, was covalently conjugated
to DOPE via an amide linkage and subsequent purifi-
cation was performed as described in Section 2. In
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Fig. 1. Structure of N-Ac-AA-DOPE and postulated scheme of conversion to DOPE by enzymatic cleavage.
Fig. 2. TLC determination of protease mediated cleavage of
N-Ac-AA-DOPE. N-Ac-AA-DOPE SUVs were incubated with
 .  . A elastase or B proteinase K 1 mg enzymer100 nmol
.lipidr0.1 ml buffer overnight at 378C. Lipid was collected and
separated by TLC. Lipid spots were developed as described in
Section 2. Lane 1, N-Ac-AA-DOPE without enzyme; lane 2,
N-Ac-AA-DOPE with enzyme treatment; lane 3, DOPE from
stock solution.
contrast to pure DOPE, stable liposomes composed
solely of N-Ac-AA-DOPE could be prepared at room
temperature, pH 7.4, indicating the addition of the
ala–ala dipeptide to the headgroup of DOPE either
elevated the H transition temperature or renderedII
the lipid incapable of converting to a non-bilayer
structure. When cleavage of N-Ac-AA-DOPE was
monitored by TLC, treatment of N-Ac-AA-DOPE
liposomes with elastase generated a product corre-
sponding to DOPE, whereas untreated N-Ac-AA-
 .DOPE showed no change Fig. 2A . Therefore, elas-
tase recognized N-Ac-AA-DOPE and cleaved the
dipeptide to yield DOPE.
3.2. Modeling of elastase mediated clea˝age of
N-Ac-AA-DOPE by proteinase K
Extensive experimentation with human leukocyte
elastase was precluded because of cost considera-
tions. Therefore, several proteases were tested to
determine whether an enzyme with similar substrate
specificity could be used as a model for elastase
mediated cleavage of N-Ac-AA-DOPE. Proteinase K
is a serine protease that, similar to elastase, can
cleave at peptide bonds C-terminal to aliphatic
residues. Upon incubation of N-Ac-AA-DOPE lipo-
somes with proteinase K, the peptide–lipid was
 .cleaved and DOPE was generated Fig. 2B . The
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conversion of N-Ac-AA-DOPE to DOPE was also
monitored by 31P-NMR analysis. N-Ac-AA-DOPE
liposomes treated with proteinase K 1.5 mg pro-
.teaser100 nmol lipid resulted in the appearance of a
peak 0.3 ppm upfield from N-Ac-AA-DOPE, corre-
 .sponding to pure DOPE unpublished data .
Elastase and proteinase K mediated cleavage of
N-Ac-AA-DOPE was quantitated using liposomes
composed of N-Ac-AA-DOPE and DOTAP, a posi-
tively charged lipid. DOTAP was included to provide
 .a counterbalancing positive charge see Section 3.3 ,
and was used as a standard by which different sam-
ples could be normalized and compared. After treat-
ment with elastase or proteinase K the reduction in
the amount of N-Ac-AA-DOPE was monitored by
HPLC. Both enzymes cleaved N-Ac-AA-DOPE to a
 .similar extent Fig. 3 . To verify that the cleavage of
N-Ac-AA-DOPE was due to proteinase K enzymatic
activity, liposomes were treated with heat inactivated
proteinase K. Proteinase K was inactivated by heating
at 958C for 1 h, after which the enzyme was inca-
pable of cleaving the chromogenic substrate N-Ac-
 .AAA-pNA unpublished data . Treatment of
Fig. 3. Proteinase K mediated cleavage of N-Ac-AA-DOPE.
 .DOTAPrN-Ac-AA-DOPE 1:1 SUVs were incubated with or
without elastase, proteinase K, or heat inactivated proteinase K
 .958C, 1 h at a 1 mg proteaser100 nmolr0.1 ml buffer lipid
concentration overnight at 378C. Lipid was collected and ana-
lyzed by HPLC. The N-Ac-AA-DOPE peak was quantitated and
the amount of cleavage was calculated as a percentage of the
starting lipid.
Fig. 4. Determination of optimal liposomal composition. Lipo-
somes were prepared in given molar ratios of DOTAP, N-Ac-
AA-DOPE, PE. A total of 1 mol% N-NBD-PE and N-Rho-PE
fluorescent probes were included in all preparations. Liposomes
 . were mixed with A unlabeled PErPS or PCrPS 80r20 mol%;
.  . 81:10 effector:acceptor ratio; 60 mM total lipid or B 2=10
RBC ghosts at 378C for 1 h. Lipid mixing was calculated as the
percentage of N-NBD-PE FDQ relative to maximal FDQ, as
determined by detergent addition. Binding of liposomes to RBC
ghosts was quantitated after washing cells with buffer by calcu-
lating the amount of N-Rho-PE fluorescence associated with the
cell pellet relative to the total input fluorescence.
DOTAPrN-Ac-AA-DOPE liposomes with heat inac-
tivated proteinase K did not result in any cleavage of
 .N-Ac-AA-DOPE Fig. 3 , indicating the requirement
for active proteinase K. Since proteinase K has been
shown to share substrate specificity with elastase
w x22,23 and is considerably less costly than human
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Fig. 5. Elastase and proteinase K mediated activation of liposo-
mal lipid mixing. DOTAPrN-Ac-AA-DOPErPE 15r15r70
.mol% liposomes containing fluorescent membrane probes were
pretreated with human leukocyte elastase or proteinase K 1 mg
.proteinr100 nmol lipidr0.1 ml buffer overnight at 378C. Some
10 nmol aliquots were incubated with unlabeled PErPS acceptor
 .liposomes 80r20 mol%; 1:10 effector:acceptor ratio for 60 min
at 378C. Lipid mixing was determined by monitoring N-NBD-PE
FDQ.
Fig. 6. Requirement for active proteinase K for DOTAPrN-Ac-
AA-DOPErPE liposome lipid mixing activation with PSrPE
 .liposomes. DOTAPrN-Ac-AA-DOPErPE 15r15r70 mol% li-
 .posomes 100 nmol containing fluorescent membrane probes
were pretreated with or without 1 mg of proteinase K or heat
 .inactivated proteinase K 1 h, 958C overnight at 378C in 0.1 ml
buffer. Aliquots of 10 nmol were incubated with unlabeled
PErPS acceptor liposomes 80r20 mol%; 1:10 effector:acceptor
.ratio , after which lipid mixing was determined. Prot K carryover
seffect of residual proteinase K carried over to incubation
mixture with PErPS liposomes was monitored by incubating
 .untreated DOTAPrN-Ac-AA-DOPErPE 15r15r70 mol% li-
posomes with PErPS liposomes in presence of freshly added
proteinase K equivalent to the expected transferred amount see
.text .
leukocyte elastase, the majority of subsequent experi-
ments were conducted with proteinase K.
3.3. Design of fusion-triggerable liposomes
containing N-Ac-AA-DOPE
Liposomes containing N-Ac-AA-DOPE were de-
 .signed with the following goals in mind: 1 formu-
late liposomes with the maximum amount of PE so as
to maximize the fusogenic potential without actually
Fig. 7. Concentration and time dependence of proteinase K
activity. Activation of lipid mixing: DOTAPrN-Ac-AA-
 .  .DOPErPE 15r15r70 mol% liposomes 100 nmol containing
fluorescent membrane probes were incubated in 0.1 ml buffer at
 .378C either A overnight with given amounts of proteinase K or
 .B with 1 mg proteinase K for given times. Aliquots of 10 nmol
were incubated with unlabeled PErPS acceptor liposomes 80r20
.mol%; 1:10 effector:acceptor ratio , after which lipid mixing was
determined. N-Ac-AA-DOPE cleavage: unlabeled DOTAPrN-
 .Ac-AA-DOPE 1:1 mol ratio liposomes were treated identically
as for fusion activation, after which lipid was extracted and
analyzed by HPLC.
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Fig. 8. Activation of DOTAPrN-Ac-AA-DOPErPE liposomes
by proteinase K for lipid mixing with RBC ghosts. DOTAPrN-
 .  .Ac-AA-DOPErPE 20r10r70 mol% liposomes 100 nmol
containing fluorescent membrane probes were incubated overnight
at 378C with or without 1 mg of proteinase K in 0.1 ml buffer.
Aliquots of 10 nmol of DOTAPrN-Ac-AA-DOPErPE lipo-
 .somes as well as DOTAPrPE 20r80 mol% liposomes were
incubated with 1=108 RBC ghosts in buffer containing 0.5 mM
PMSF for 30 min at 378C, after which lipid mixing was deter-
mined. Effect of transferred proteinase K on lipid mixing was
monitored by incubating untreated liposomes with RBC ghosts in
the presence of an equivalent amount of proteinase K prot K
.control .
allowing fusion in the absence of the activating trig-
 .ger, and 2 counterbalance the negatively charged
N-Ac-AA-DOPE with a positively charged lipid so
that upon conversion of the negatively charged N-
Ac-AA-DOPE to zwitterionic DOPE, the liposome
may acquire an overall positive charge. This latter
characteristic is expected to enhance the binding of
activated liposomes to cells, which tend to have an
overall negative charge. The threshold of fusogenicity
was determined by preparing liposomes with increas-
ing amounts of PE transesterified from egg PC. This
PE was preferred over DOPE because of its higher
H transition temperature ;378C vs. 108C, respec-II
.tively , which aids in the preparation of stable lipo-
somes yet does not inhibit fusion. DOTAP was cho-
sen as the positively charged lipid.
Lipid mixing assays were performed for
DOTAPrN-Ac-AA-DOPErPE liposomes containing
the fluorescent membrane probes N-NBD-PE and
N-Rho-PE and inversely varying amounts of N-Ac-
AA-DOPE and PE. These liposomes were monitored
for enhanced fusogenic potential by observing lipid
mixing with either unlabeled target liposomes or for
lipid mixing and binding with RBC ghosts. It became
readily apparent that the threshold for fusogenicity
depends upon the target in question. Liposomes com-
posed of DOTAP and PE exhibited lipid mixing with
both target liposomes and RBC ghosts, as has been
w xshown previously 24 . Inclusion of 10 mol% N-Ac-
AA-DOPE with a corresponding decrease in PE to 70
mol% generated liposomes that were still capable of
lipid mixing with PErPS liposomes but not PCrPS
 .liposomes Fig. 4A . The requirements for membrane
mixing with RBC ghosts appeared to be more strin-
gent, with inclusion of 5 mol% N-Ac-AA-DOPE
inhibiting both the lipid mixing and the binding
 .significantly Fig. 4B . Defining the different thresh-
old of fusogenicity for different targets creates a
gradient of sensitivity for fusion that can be used to
determine optimum conditions for activating N-Ac-
AA-DOPE containing liposomes to fuse. As PErPS
liposomes appeared to be the most sensitive target,
Fig. 9. DOTAPrN-Ac-AA-DOPErPE liposome with RBC
ghosts: continuous kinetics of lipid mixing. Aliquots of 10 nmol
 .of DOTAPrN-Ac-AA-DOPErPE 20r10r70 mol% liposomes
 .  .incubated a with or b without proteinase K overnight at 378C
were added to a cuvette containing 2 ml buffer with 0.5 mM
PMSF under continuous stirring and 378C conditions. N-NBD-PE
fluorescence recording was initiated and 1=108 RBC ghosts
 .were added at 30 s. c Effect of carryover proteinase K on lipid
mixing was monitored by incubating untreated liposomes with
RBC ghosts in presence of equivalent amount of proteinase K.
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we focused on a composition of DOTAPrN-Ac-AA-
DOPErPE liposomes that could be activated to fuse.
The threshold of PE content appeared to be between
65–70 mol%. In order to create a liposome that is not
initially highly positively charged, DOTAP and N-
Ac-AA-DOPE were added in equivalent amounts to
yield liposomes composed of DOTAPrN-Ac-AA-
DOPErPE in a 15r15r70 mol ratio.
3.4. Acti˝ation of liposome–liposome lipid mixing by
enzyme clea˝age
Since elastase and proteinase K were capable of
 .cleaving N-Ac-AA-DOPE to DOPE Figs. 2 and 3 ,
both enzymes were tested for their ability to activate
 .DOTAPrN-Ac-AA-DOPErPE 15r15r70 mol%
liposomes to undergo lipid mixing. These liposomes
were treated overnight at 378C with elastase, or pro-
teinase K, or without either enzyme, after which
liposomes were incubated with PErPS liposomes and
lipid mixing monitored by relief of N-NBD-PE fluo-
rescence quenching. Treatment by either enzyme re-
sulted in a greater extent of lipid mixing over that of
 .untreated liposomes Fig. 5 . This result, coupled
with the shared substrate specificity of proteinase K
and elastase, suggests proteinase K activation serves
as a suitable substitute for elastase to characterize the
fusion activation of N-Ac-AA-DOPE containing li-
posomes.
A causal relationship between cleavage of the
N-Ac-AA-DOPE peptide–lipid and fusion activation
of DOTAPrN-Ac-AA-DOPErPE liposomes was
studied using heat inactive proteinase K. DOTAPrN-
 .Ac-AA-DOPErPE 15r15r70 mol% liposomes
containing the fluorescent membrane probes N-NBD-
PE and N-Rho-PE were incubated overnight at 378C
with active or heat inactivated proteinase K, after
which an aliquot of the liposomes was incubated with
unlabeled PSrPE acceptor liposomes to monitor the
extent of lipid mixing. Treatment of DOTAPrN-Ac-
AA-DOPErPE liposomes with active proteinase K
resulted in ;30% fluorescence dequenching, a six-
fold increase in lipid mixing over the untreated lipo-
 .somes Fig. 6 . However, treatment with an identical
amount of the heat inactivated enzyme did not acti-
 .vate liposomes to mix lipids Fig. 6 . Therefore,
enzymatic activity is essential for the liposomes to
become fusogenic, indicating N-Ac-AA-DOPE
cleavage is crucial for triggering the fusogenic poten-
tial.
Because the experimental protocol involved trans-
ferring a small portion of active proteinase K 10 mg
.proteaser100 nmol lipid; 100-fold dilution along
with the pretreated liposomes to the subsequent lipo-
some–liposome incubation, it was possible that this
amount of enzyme mediated the observed lipid mix-
ing by non-specific protein effects. This possibility
was tested by adding the expected carryover amount
of active proteinase K to the untreated DOTAPrN-
Ac-AA-DOPErPE q PErPS incubation mixture.
Lipid mixing of this sample was the same as that of
 .liposomes incubated without proteinase K Fig. 6 .
Furthermore, continuous fusion kinetics showed an
immediate increase in fluorescence dequenching upon
mixing of proteinase K treated DOTAPrN-Ac-AA-
DOPErPE liposomes with PSrPE liposomes unpub-
.lished data . The enzymatically triggered threshold
would presumably not be reached immediately, sug-
gesting non-specific enzymatic cleavage of target
liposomes was not responsible for fusion. The mere
presence of protein cannot be responsible for fluores-
cence dequenching, as heat inactivated proteinase K
did not mediate a similar response. Conversely, pro-
teinase K did not physically prevent fluorescence
dequenching, as exogenous proteinase K added to
mixtures of the fusogenic DOTAPrPE liposomes
with target liposomes did not inhibit lipid mixing
 .unpublished data . Taken together, these results indi-
cate that only pretreatment with enzymatically active
proteinase K triggers fusion of N-Ac-AA-DOPE con-
taining liposomes.
The reliance of activation upon enzyme cleavage
of N-Ac-AA-DOPE was further assessed by examin-
ing the concentration and time dependencies of both
Fig. 10. Dextran loaded DOTAPrN-Ac-AA-DOPErPE liposome fusion with RBC ghosts. DOTAPrN-Ac-AA-DOPErPE 20r10r70
.mol% liposomes were loaded with 10 kDa TX-red conjugated dextrans. Liposomes were incubated with proteinase K overnight at 378C.
 .  . 8Aliquots of 40 nmol of dextran loaded liposomes A, C or unloaded liposomesq free dextran B, D were incubated with 1=10 RBC
 .ghosts in 1 ml buffer for 30 min at 378C, after which the cells were washed and observed by fluorescence microscopy A, B or Nomarski
 .differential interference contrast C, D .
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events. DOTAPrN-Ac-AA-DOPErPE liposomes
were either incubated with 0, 0.1, 0.25, 0.5, and 1 mg
proteinase Kr100 nmol lipid overnight, or with 1 mg
proteinase Kr100 nmol lipid for 1, 2, 4 h or overnight.
These liposomes were monitored for N-Ac-AA-DOPE
cleavage by HPLC or for lipid mixing with acceptor
liposomes by N-NBD-PE fluorescence dequenching.
A similar concentration dependence was evident for
both N-Ac-AA-DOPE cleavage and liposomal lipid
 .mixing Fig. 7A . Treatment with 0.5 or 1 mg pro-
teinase K yielded apparently maximal cleavage and
fusion activity. Only background levels of both activ-
ities were observed when 0 or 0.1 mg of the enzyme
were used. The kinetics of proteinase K mediated
cleavage and fusion activation were also correlated,
with overnight incubation giving the highest amount
 .of cleavage and lipid mixing Fig. 7B . These results
further support the contention that the activation of
fusogenicity of DOTAPrN-Ac-AA-DOPErPE lipo-
somes is due to enzymatic cleavage of N-Ac-AA-
DOPE.
3.5. Acti˝ation of DOTAPr N-Ac-AA-DOPEr PE
fusion with RBC ghosts
Since DOTAPrN-Ac-AA-DOPErPE liposomes
could be activated to lipid mix with target liposomes
after enzymatic cleavage, we determined if the acti-
vated fusogenicity of N-Ac-AA-DOPE containing
liposomes with cells could also be observed. As lipid
 .mixing with RBC ghosts Fig. 4B appeared to ex-
 .hibit a different threshold than liposomes Fig. 4A ,
we prepared DOTAPrN-Ac-AA-DOPErPE lipo-
somes at a 20r10r70 mol ratio. The overall positive
charge of these liposomes improves the binding to
cells, relative to the 15r15r70 composition, but the
positive charge is not high enough to induce lipo-
some fusion with cells in the absence of an activation
 .trigger Fig. 4B, unpublished data . After an
overnight, 378C, incubation of these liposomes with
proteinase K, lipid mixing with RBC ghosts was
observed in the presence of the protease inhibitor
 .PMSF Fig. 8 . The activity of residual proteinase K
transferred from the initial incubation was negligible
 .Fig. 8 . Specific activation of DOTAPrN-Ac-AA-
 .DOPErPE 20r10r70 mol% lipid mixing with RBC
ghosts was also observed under continuous kinetics
conditions. Only liposomes pretreated with proteinase
K were capable of apparently fusing with RBC ghosts
 .while untreated liposomes did not Fig. 9 . The addi-
tion of active proteinase K to untreated liposomes
also did not induce fluorescence dequenching Fig. 9,
.curve c , indicating the observed increase for pro-
teinase K treated DOTAPrN-Ac-AA-DOPErPE li-
posomes was due to specific activation of lipid mix-
ing, and presumably, fusion.
To determine if the lipid mixing observed after
proteinase K activation was due to true fusion of
liposomes with cells and not potential artifacts of the
lipid mixing assay, such as membrane probe ex-
change or hemifusion between outer leaflet mem-
branes, DOTAPrN-Ac-AA-DOPErPE 20r10r70
.mol% liposomes were loaded with 10,000 MW fluo-
rescent aqueous probe TX-red dextran. Dextrans were
 3qused because small MW probes e.g., Tb , 159
. MW rapidly leaked from the liposomes unpublished
.observations . Liposomes were then treated with pro-
teinase K and incubated with RBC ghosts. After
washing the cells extensively to remove unbound
liposomes, the RBC ghosts were observed under
fluorescence microscopy. Bright diffuse fluorescence
 .could be observed in a portion of the cells Fig. 10 ,
indicating complete fusion occurred between lipo-
somes and certain cells with subsequent transfer of
the fluorescent aqueous probe. Differences in fluores-
cence levels may be due to differences in the number
of liposomes fusing with a single cell. The observed
fluorescence does not appear to be due to non-specific
uptake of dextran out of leaky liposomes, as incuba-
tion of RBC ghosts with unlabeled liposomes and
free TX-red dextran did not result in observable
 .aqueous probe labeling Fig. 10 . Thus, DOTAPrN-
Ac-AA-DOPErPE liposomes can be activated by
enzymatic cleavage of the peptide–lipid to fuse with
cells and deliver their aqueous contents.
4. Discussion
Liposomes have been activated to fuse or release
their internal contents by a variety of triggering sig-
nals. pH sensitive lipids have been included in liposo-
mal formulations such that exposure to an acidic
environment mimicking the endosome destabilizes
the liposomal membrane and in some cases leads to
w xfusion 3–7 . Photoactivation has been used to either
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w xgenerate membrane destabilizing surfactants 7 or to
polymerize photosensitive lipids such that enriched
w xDOPE domains could form and promote fusion 8 .
w xPhospholipase C activation 9,10 , chemical cleavage
w x w x11 , and trypsin mediated cleavage 12 have also
been used with specific liposomal formulations to
generate fusogenic liposomes. These approaches have
their unique advantages and disadvantages. Activa-
tion of fusion by light has the advantage that the
triggering signal can be tightly controlled but in turn
is limited to sites where the activating signal can be
directed. Low pH sensitive liposomes are effective in
releasing their aqueous contents under acidic condi-
w xtions 4 and have been shown to deliver their encap-
w xsulated contents to cells 5,25 . Unfortunately, non-
endocytic cells are excluded as delivery targets and
fusion are not actively physiologically targeted. Fur-
thermore, it may be advantageous to avoid the endo-
somes for low pH sensitive molecules. Phospholipase
C triggered fusion depends on an enzyme that is not
selectively found at pathological sites. Chemical and
trypsin dependent cleavage are not feasible for in
vivo applications.
Recent reports of protease mediated delivery sys-
tems indicate the appeal of this approach. Peng et al.
w x26 showed that expression in retrovirus of epider-
 .mal growth factor EGF linked to a viral envelope
 .glycoprotein via a matrix metalloproteinase MMP
cleavage signal enhanced the ability of the retrovirus
to infect cells expressing MMP and EGF receptor.
However, this vector presumably still suffers from
the problems associated with retrovirus delivery, such
as immunogenicity and potential active virus produc-
tion. Another application of protease activation is the
modification of a-hemolysin, a self-assembling,
pore-forming bacterial protein. a-Hemolysin has been
remodeled so that the pore-forming ability can be
activated by a number of triggers, including cathepsin
w xB, a protease secreted by certain tumor cells 27 .
Development of a delivery system based on modified
a-hemolysin has not been described as of yet. These
reports demonstrate the potential of an enzyme trig-
gered system.
Covalent conjugation of the ala–ala dipeptide to
DOPE generates a novel peptide–lipid that differs
from DOPE in two significant ways. First, the overall
shape of the phospholipid may be converted from
that of an inverted cone to a cylindrical form, which
apparently affects the intrinsic curvature of the phos-
pholipid such that its fusogenic potential is reduced
and its ability to form stable membrane bilayers is
enhanced. Thus, the finding that liposomes composed
solely of N-Ac-AA-DOPE can be prepared at neutral
pH is not unexpected. Second, the overall charge of
the phospholipid changes from net neutral to negative
 .Fig. 1 . Both the size and charge effects are reversed
upon removal of the N-Ac-ala–ala headgroup by
protease treatment, resulting in enhanced fusogenicity
and loss of negative charge.
We took advantage of these properties to design
liposomes that would be quiescent until activated to
fuse by enzymatic cleavage. Liposomes with this
property could prove to be superior to liposomes that
are inherently fusogenic. The charge reversibility of
N-Ac-AA-DOPE containing liposomes is an attrac-
tive feature because it permits the preparation of
negatively charged liposomes, which has been shown
to decrease liposomal aggregation and increase in
vivo circulation for certain liposomal formulations
w x28 . Further refinements of the liposomal composi-
tion may involve substitution of a specific targeting
component for the positively charged lipid. This
would permit retention of the negative charge and
triggerable fusogenicity while selectively delivering
the liposome and its contents. We also foresee the
inclusion of components that facilitate in vivo circu-
lation or alternate fusogenic lipids to promote fusion
under different conditions. This modular approach to
liposome design would permit us to prepare delivery
vehicles that are best suited for a given environment.
Several potential mechanisms by which cleavage
of N-Ac-AA-DOPE mediates liposomal fusion may
be postulated. Previously described triggerable sys-
tems appear to proceed by one of two mechanisms,
depending upon the composition of the liposomes.
One mechanism relies upon temporarily stabilizing
PE with a labile component, then releasing the inher-
ent fusogenicity of the liposome by modification of
the latter component. Another method to trigger fu-
sion or liposomal contents release is the generation in
situ of membrane destabilizing components. Fusion
of N-Ac-AA-DOPE containing liposomes can con-
ceivably proceed by a combination of the two meth-
ods. The conversion of N-Ac-AA-DOPE to DOPE by
active proteinase K generates additional DOPE that
may drive the liposomes over the threshold of nega-
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w xtive curvature stress required for fusion 29,30 . At
the same time, the decrease in negatively charged
N-Ac-AA-DOPE may reduce the charge repulsion
between liposomal and cell membranes. Furthermore,
an additional mechanism of action for membrane
destabilization and subsequent fusion may derive from
generation of a transmembrane asymmetry in PE
content. If the localized increase of DOPE is confined
to the outer leaflet, it may enhance the propensity for
negative curvature on the outer monolayer without
affecting the inner monolayer. Several experiments
w x31,32 suggest that fusion can be optimized by in-
duction of negative curvature stress in the outer
monolayer, but the inner monolayer may require
lipids inducing positive curvature stress. Fusion may,
in fact, be inhibited by induction of negative curva-
w xture stress on the inner monolayer 33 .
Improvements in the design of the enzyme sub-
strate may enhance the efficiency of enzyme acti-
vated liposomal fusion. One approach may be to
substitute a more reactive enzyme substrate for N-
Ac-ala–ala. This dipeptide was chosen for conjuga-
tion with DOPE because of its greater reactivity with
w xelastase 34 , relative to a single alanine linked to a
w xchromogenic substrate 16 , as well as to minimize
immunogenic potential. However, other peptide se-
quences such as ala–ala–pro–val have a higher
w xturnover rate for cleavage 34 . Therefore, conjuga-
tion of this peptide or similar peptide sequences to
DOPE may enhance the proteolytic cleavage. It was
also shown that increased solubility of synthetic sub-
strates was related to enhanced cleavage by human
w xleukocyte elastase 34 . Thus, the efficiency of pep-
tide–lipid cleavage may also be improved by substi-
tuting the N-acetyl group of N-Ac-ala–ala with alter-
natives with greater hydrophilicity.
The variety of proteolytic enzymes present within
the inflammatory environment may provide another
method to enhance the cleavage and fusion activation
of peptide–lipid liposomes. Activated neutrophils re-
lease numerous enzymes in addition to elastase, such
as cathepsin G and the matrix metalloproteinases
w x w xgelatinase 35 and collagenase 36 . A similar sub-
strate specificity between cathepsin G and elastase
w x w x34 and among MMPs 37,38 suggests that some
peptide–lipids containing a substrate for elastase may
also be cleaved by other neutrophil derived enzymes,
thereby enhancing the activation of fusion.
The ubiquitous nature of elastase at inflammatory
sites hints at the potential applications of an elastase
susceptible peptide–lipid. Elastase and the neu-
trophils from which it is produced have been impli-
cated as contributing factors to rheumatoid arthritis
w x w x21,39 , acute respiratory distress syndrome 40 , em-
w x w xphysema 41 , and cystic fibrosis 42,43 . Elevated
levels of elastase have also been associated with
w x w xbreast 44 and skin cancer 45 . Liposomes com-
posed of N-Ac-AA-DOPE could be suitable delivery
vehicles for therapeutic agents to these sites. Further-
more, other disease states may be addressed by sub-
stitution of the elastase substrate of the peptide–lipid
with substrates for other enzymes. For example,
metastases of tumor cells may be targeted because of
their correlation with elevated matrix metallopro-
w xteinase levels 46 . This study demonstrates that the
general concept of enzyme cleavage triggered fusion
is feasible and holds promise as a means of directed
delivery.
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